Bipolar Disorder Market size worth $ 6.27 Billion, Globally, by 2030 at 2% CAGR: Verified Market Research®

News provided by

Jul 11, 2023, 10:15 ET

The "Global Bipolar Disorder Market Size By Mechanism of Action (Monoamine Oxidase Inhibitors, Benzodiazepines, Beta Blockers), By Drug Class (Mood Stabilizer, Antipsychotic Drugs, Antidepressant Drugs), By Geographic Scope And Forecast" report has been published by Verified Market Research^®. The report provides an in-depth analysis of the global Bipolar Disorder Market, including its growth prospects, market trends, and market challenges.

JERSEY CITY, N.J., July 11, 2023 /PRNewswire/ -- The Global Bipolar Disorder Market is projected to grow at a CAGR of 2% from 2023 to 2030, according to a new report published by Verified Market Research^®. The report reveals that the market was valued at USD 5.25 Billion in 2021 and is expected to reach USD 6.27 Billion by the end of the forecast period.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=33465

Browse in-depth TOC on "Bipolar Disorder Market"
202 - Pages
126 – Tables
37 – Figures

Global Bipolar Disorder Market: Increased Awareness and Technological Advancements Drive Market Growth

The global Bipolar Disorder market is experiencing significant growth, driven by increased awareness, expanding treatment options, and technological advancements in genetic disorder identification. Market research analysis conducted by industry experts highlights the drivers, constraints, and growth opportunities within the market.

Bipolar Disorder, also known as manic depression, is a mental illness characterized by mood swings. This market analysis delves into the global Bipolar Disorder market, exploring the factors that shape its trajectory. Increased awareness about the diagnosis and treatment of Bipolar Disorder plays a pivotal role in driving market growth. Societal acceptance of mental illness has improved, facilitating greater access to treatment options for affected individuals. Furthermore, technological advancements in identifying genetic disorders and an expanding treatment landscape contribute significantly to the market's maturity.

Government initiatives, such as the Bipolar Disorder Phenome Database funded by the National Institute of Mental Health (NIMH), provide comprehensive information on the signs and symptoms of the illness, further supporting market growth. These efforts enable healthcare professionals and patients to enhance their understanding of Bipolar Disorder and promote efficient diagnosis and treatment.

Despite the market's growth prospects, there are several constraints and limitations that hinder its expansion. Stringent regulatory frameworks pose challenges to market growth, necessitating careful navigation for industry stakeholders. Additionally, the side effects associated with anticonvulsant medications and the limited number of approved anticonvulsants further restrict market growth. Overcoming these challenges requires collaboration between regulatory bodies and industry players to ensure the availability of safe and effective treatment options.

However, the Bipolar Disorder market also presents various growth opportunities. Constant technological developments, including the utilization of smartphones, smartwatches, and wearable devices, hold the potential to improve diagnosis and treatment outcomes. These innovations enable healthcare providers and patients to monitor and manage the condition effectively. Furthermore, emerging markets offer untapped opportunities for market expansion, as awareness of mental health issues continues to grow worldwide.

The antipsychotic drug segment holds the largest market share during the forecast period. This segment is commonly used in combination therapy with selective serotonin reuptake inhibitors (SSRIs), demonstrating favorable results and leading to increased adoption among physicians. The effectiveness and positive patient outcomes associated with this treatment approach contribute to the segment's dominance.

North America dominates the global Bipolar Disorder market, holding the largest market share. Several factors contribute to this regional dominance, including high stress levels, insufficient sleep patterns, the prevalence of substance abuse among the population, and ongoing research projects. The region's robust healthcare infrastructure and supportive initiatives play a crucial role in addressing the needs of individuals affected by Bipolar Disorder.

Key players in the Bipolar Disorder market include Otsuka Holdings Co. Ltd, Glaxo SmithKline (GSK), Janssen Pharmaceuticals, Allergan Plc., Novartis AG, AbbVie Inc., Eli Lilly, Pfizer Inc., and AstraZeneca. These companies are at the forefront of research, development, and innovation in the field. Financial statements, product benchmarking, SWOT analysis, key development strategies, market share analysis, and market positioning analysis provide insights into their market presence and future prospects.

In conclusion, the global Bipolar Disorder market is experiencing significant growth driven by increased awareness, societal acceptance, advancements in genetic disorder identification, and expanding treatment options. While regulatory constraints and limited approved medications pose challenges, technological advancements, the use of smart devices, and untapped opportunities in emerging markets offer promising growth prospects. The dominance of the antipsychotic drug segment and North America's market share further underline the market's potential.

To get market data, market insights, financial statements and a comprehensive analysis of the Global Bipolar Disorder Market, please Contact Verified Market Research®.

Based on the research, Verified Market Research® has segmented the global Bipolar Disorder Market into Mechanism of Action, Drug Class, And Geography.

Bipolar Disorder Market, by Mechanism of Action

Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drugs
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
Others

Bipolar Disorder Market, by Drug Class

Mood Stabilizer
Antipsychotic Drugs
Antidepressant Drugs
Anticonvulsants
Antianxiety Drugs

Bipolar Disorder Market, by Geography

North America

U.S
Canada
Mexico

Europe

Germany
France
U.K
Rest of Europe

Asia Pacific

China
Japan
India
Rest of Asia Pacific

ROW

Middle East & Africa
Latin America

Browse Related Reports:

Bipolar Forceps Products Market By Type (Disposable and Reusable), By Application (Gynecology, General surgery), By End-Use (Hospitals, Specialty Clinics), By Geography, And Forecast

Bipolar Electrosurgical Devices Market By Product (Advanced Vessel Sealing Devices, Bipolar Forceps), By Surgical Application (General Surgery, Gynecology Surgery), By End-User (Hospitals, Ambulatory Surgical Centers), By Geography, And Forecast

Antipsychotic Drugs Market By Drug Class (First Generation, Second Generation), By Application (Schizophrenia, Bipolar Disorders), By Geography, And Forecast

Bipolar Disorder Therapeutic Sales Market By Product (Antipsychotics, Anticonvulsants, Mood Stabilizers), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography, And Forecast

Top 10 Biopharmaceutical Companies synthesizing biological sources for global patients

Visualize Bipolar Disorder Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research^® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research^®US: +1 (650)-781-4080
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg

SOURCE Verified Market Research